Three novel candidate probiotic strains with prophylactic properties in a murine model of cow's milk allergy

Applied and Environmental Microbiology

Volumn 82, Issue 6, 2016, Pages 1722-1733

  Neau, Elodie ^a,b   Delannoy, Johanne ^a   Marion, Candice ^a   Cottart, Charles Henry ^c,d   Labellie, Chantal ^a   Holowacz, Sophie ^b   Butel, Marie José ^a   Kapel, Nathalie ^a,e   Waligora Dupriet, Anne Judith ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Groupe PiLeJe   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d INSTITUT NECKER ENFANTS MALADES   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIA; DRUG PRODUCTS; LACTIC ACID; STAINLESS STEEL; STRAIN; DAIRIES; MAMMALS; PROBIOTICS;

BETA-LACTOGLOBULIN; BIFIDOBACTERIUM LONGUM; DIFFERENT MECHANISMS; HUMAN PERIPHERAL BLOOD; IMMUNOMODULATORY; LACTIC ACID BACTERIA; LACTOBACILLUS RHAMNOSUS; PROBIOTIC STRAIN;

ALLERGIES;

ALLERGY; ANTIBODY; BACTERIUM; CELLS AND CELL COMPONENTS; IMMUNE SYSTEM; MORBIDITY; ORGANIC ACID; PROBIOTICS; QUALITY OF LIFE; RISK ASSESSMENT; RODENT;

BIFIDOBACTERIUM LONGUM; LACTOBACILLUS RHAMNOSUS; LACTOBACILLUS SALIVARIUS; MURINAE; MUS;

CYTOKINE; PROBIOTIC AGENT;

ANIMAL; BIFIDOBACTERIUM; CELL CULTURE; DISEASE MODEL; HELPER CELL; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LACTOBACILLALES; MILK HYPERSENSITIVITY; MONONUCLEAR CELL; MOUSE; SECRETION (PROCESS); TREATMENT OUTCOME;

ANIMALS; BIFIDOBACTERIUM; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; LACTOBACILLALES; LEUKOCYTES, MONONUCLEAR; MICE; MILK HYPERSENSITIVITY; PROBIOTICS; T-LYMPHOCYTES, HELPER-INDUCER; TREATMENT OUTCOME;

EID: 84961275870     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03440-15     Document Type: Article

References (49)

1. Dupont C. 2011. Food allergy: recent advances in pathophysiology and diagnosis. Ann Nutr Metab 59(Suppl):S8-S18
2. Chistiakov DA, Bobryshev YV, Kozarov E, Sobenin IA, Orekhov AN. 2015. Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance. Front Microbiol 5:781
3. Slack E, Hapfelmeier S, Stecher B, Velykoredko Y, Stoel M, Lawson MA, Geuking MB, Beutler B, Tedder TF, Hardt WD, Bercik P, Verdu EF, McCoy KD, Macpherson AJ. 2009. Innate and adaptive immunity cooperate flexibly to maintain host-microbiota mutualism. Science 325: 617-620. http://dx.doi.org/10.1126/science.1172747
4. Waligora-Dupriet AJ, Butel MJ. 2012. Microbiota and allergy: from dysbiosis to probiotics, p 413-434. In PereiraC(ed), Allergic diseases-highlights in the clinic, mechanisms and treatment. InTech, Rijeka, Croatia. http://www.intechopen.com/books/allergic-diseaseshighlights-in-the-clinic-mechanisms-and-treatment/microbiota-and-allergy-from-dysbiosis-to-probiotics
5. Gordon BR. 2011. The allergic march: can we prevent allergies and asthma? Otolaryngol Clin North Am 44:765-777. http://dx.doi.org/10.1016/j.otc.2011.03.006
6. FAO/WHO Working Group. 2002. Guidelines for the evaluation of probiotics in food. FAO/WHO, London, Ontario, Canada
7. Shen J, Zuo ZX, Mao AP. 2014. Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. Inflamm Bowel Dis 20:21-35. http://dx.doi.org/10.1097/01.MIB.0000437495.30052.be
8. Fiocchi A, Pawankar R, Cuello-Garcia C, Ahn K, Al-Hammadi S, Agarwal A, Beyer K, Burks W, Canonica GW, Ebisawa M, Gandhi S, Kamenwa R, Lee BW, Li H, Prescott S, Riva JJ, Rosenwasser L, Sampson H, Spigler M, Terracciano L, Vereda-Ortiz A, Waserman S, Yepes-Nunez JJ, Brozek JL, Schunemann HJ. 2015. World Allergy Organization-McMaster University guidelines for allergic disease prevention (GLAD-P): probiotics. World Allergy Organ J 8:4. http://dx.doi.org/10.1186/s40413-015-0055-2
9. Kim HJ, Kim HY, Lee SY, Seo JH, Lee E, Hong SJ. 2013. Clinical efficacy and mechanism of probiotics in allergic diseases. Korean J Pediatr 56:369-376. http://dx.doi.org/10.3345/kjp.2013.56.9.369
10. Kuitunen M. 2013. Probiotics and prebiotics in preventing food allergy and eczema. Curr Opin Allergy Clin Immunol 13:280-286
11. Folster-Holst R, Muller F, Schnopp N, Abeck D, Kreiselmaier I, Lenz T, von Rüden U, Schrezenmeir J, Christophers E, Weichenthal M. 2006. Prospective, randomized controlled trial on Lactobacillus rhamnosus in infants with moderate to severe atopic dermatitis. Br J Dermatol 155: 1256-1261. http://dx.doi.org/10.1111/j.1365-2133.2006.07558.x
12. Helin T, Haahtela S, Haahtela T. 2002. No effect of oral treatment with an intestinal bacterial strain, Lactobacillus rhamnosus (ATCC 53103), on birch-pollen allergy: a placebo-controlled double-blind study. Allergy 57: 243-246. http://dx.doi.org/10.1034/j.1398-9995.2002.1s3299.x
13. Castellazzi AM, Valsecchi C, Caimmi S, Licari A, Marseglia A, Leoni MC, Caimmi D, Miraglia del Giudice M, Leonardi S, La Rosa M, Marseglia GL. 2013. Probiotics and food allergy. Ital J Pediatr 39:47. http://dx.doi.org/10.1186/1824-7288-39-47
14. Foligne B, Nutten S, Grangette C, Dennin V, Goudercourt D, Poiret S, Dewulf J, Brassart D, Mercenier A, Pot B. 2007. Correlation between in vitro and in vivo immunomodulatory properties of lactic acid bacteria. World J Gastroenterol 13:236-243. http://dx.doi.org/10.3748/wjg.v13.i2.236
15. Santos Rocha C, Lakhdari O, Blottiere HM, Blugeon S, Sokol H, Bermudez-Humaran LG, Azevedo V, Miyoshi A, Dore J, Langella P, Maguin E, van de Guchte M. 2012. Anti-inflammatory properties of dairy lactobacilli. Inflamm Bowel Dis 18:657-666. http://dx.doi.org/10.1002/ibd.21834
16. Kechaou N, Chain F, Gratadoux JJ, Blugeon S, Bertho N, Chevalier C, Le Goffic R, Courau S, Molimard P, Chatel JM, Langella P, Bermudez-Humaran LG. 2013. Identification of one novel candidate probiotic Lactobacillus plantarum strain active against influenza virus infection in mice by a large-scale screening. Appl Environ Microbiol 79:1491-1499. http://dx.doi.org/10.1128/AEM.03075-12
17. Li XM, Schofield BH, Huang CK, Kleiner GI, Sampson HA. 1999. A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 103:206-214. http://dx.doi.org/10.1016/S0091-6749(99)70492-6
18. Rodriguez B, Prioult G, Bibiloni R, Nicolis I, Mercenier A, Butel MJ, Waligora-Dupriet AJ. 2011. Germ-free status and altered caecal subdominant microbiota are associated with a high susceptibility to cow's milk allergy in mice. FEMS Microbiol Ecol 76:133-144. http://dx.doi.org/10.1111/j.1574-6941.2010.01035.x
19. Du C, Nilsson S, Lu H, Yin J, Jiang N, Wahlgren M, Chen Q. 2010. Immunogenicity of the Plasmodium falciparum Pf332-DBL domain in combination with different adjuvants. Vaccine 28:4977-4983. http://dx.doi.org/10.1016/j.vaccine.2010.05.027
20. -ΔΔCT method. Methods 25: 402-408. http://dx.doi.org/10.1006/meth.2001.1262
21. Waligora-Dupriet AJ, Campeotto F, Nicolis I, Bonet A, Soulaines P, Dupont C, Butel MJ. 2007. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Int J Food Microbiol 113:108-113. http://dx.doi.org/10.1016/j.ijfoodmicro.2006.07.009
22. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O'Mahony L, Palomares O, Rhyner C, Ouaked N, Schaffartzik A, Van De Veen W, Zeller S, Zimmermann M, Akdis CA. 2011. Interleukins, from 1 to 37, and interferon-gamma: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127:701-721. http://dx.doi.org/10.1016/j.jaci.2010.11.050
23. Meijerink M, Wells JM, Taverne N, de Zeeuw Brouwer ML, Hilhorst B, Venema K, van Bilsen J. 2012. Immunomodulatory effects of potential probiotics in a mouse peanut sensitization model. FEMS Immunol Med Microbiol 65:488-496. http://dx.doi.org/10.1111/j.1574-695X.2012.00981.x
24. Niers LE, Timmerman HM, Rijkers GT, van Bleek GM, van Uden NO, Knol EF, Kapsenberg ML, Kimpen JL, Hoekstra MO. 2005. Identification of strong interleukin-10 inducing lactic acid bacteria which downregulate T helper type 2 cytokines. Clin Exp Allergy 35:1481-1489. http://dx.doi.org/10.1111/j.1365-2222.2005.02375.x
25. Menard O, Butel MJ, Gaboriau-Routhiau V, Waligora-Dupriet AJ. 2008. Gnotobiotic mouse immune response induced by Bifidobacterium sp. strains isolated from infants. Appl Environ Microbiol 74:660-666. http://dx.doi.org/10.1128/AEM.01261-07
26. Latvala S, Miettinen M, Kekkonen RA, Korpela R, Julkunen I. 2011. Lactobacillus rhamnosus GG and Streptococcus thermophilus induce suppressor of cytokine signalling 3 (SOCS3) gene expression directly and indirectly via interleukin-10 in human primary macrophages. Clin Exp Immunol 165:94-103. http://dx.doi.org/10.1111/j.1365-2249.2011.04408.x
27. Kwon HK, Lee CG, So JS, Chae CS, Hwang JS, Sahoo A, Nam JH, Rhee JH, Hwang KC, Im SH. 2010. Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders. Proc Natl Acad Sci U S A 107:2159-2164. http://dx.doi.org/10.1073/pnas.0904055107
28. Fujiwara D, Inoue S, Wakabayashi H, Fujii T. 2004. The anti-allergic effects of lactic acid bacteria are strain dependent and mediated by effects on both Th1/Th2 cytokine expression and balance. Int Arch Allergy Immunol 135:205-215. http://dx.doi.org/10.1159/000081305
29. Neau E, Butel MJ, Waligora-Dupriet AJ. 2015. Probiotics and allergic diseases-usefulness of animal models-from strains selection to mechanistic studies, p 125-151. In PereiraC(ed), Allergic diseases-new insights. InTech, Rijeka, Croatia. http://www.intechopen.com/books/allergic-diseases-new-insights/probiotics-and-allergic-diseases-usefulness-of-animal-models-from-strains-selection-to-mechanistic-s
30. Akdis CA, Akdis M. 2009. Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123:735-746. http://dx.doi.org/10.1016/j.jaci.2009.02.030
31. Pohjavuori E, Viljanen M, Korpela R, Kuitunen M, Tiittanen M, Vaarala O, Savilahti E. 2004. Lactobacillus GG effect in increasing IFNgamma production in infants with cow's milk allergy. J Allergy Clin Immunol 114:131-136. http://dx.doi.org/10.1016/j.jaci.2004.03.036
32. Pessi T, Sutas Y, Hurme M, Isolauri E. 2000. Interleukin-10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin Exp Allergy 30:1804-1808. http://dx.doi.org/10.1046/j.1365-2222.2000.00948.x
33. Holvoet S, Zuercher AW, Julien-Javaux F, Perrot M, Mercenier A. 2013. Characterization of candidate anti-allergic probiotic strains in a model of Th2-skewed human peripheral blood mononuclear cells. Int Arch Allergy Immunol 161:142-154. http://dx.doi.org/10.1159/000343703
34. Bae CJ, Lee JW, Shim SB, Jee SW, Lee SH, Woo JM, Lee CK, Hwang DY. 2011. GATA binding protein 3 overexpression and suppression significantly contribute to the regulation of allergic skin inflammation. Int J Mol Med 28:171-179
35. Pellerin L, Jenks JA, Begin P, Bacchetta R, Nadeau KC. 2014. Regulatory T cells and their roles in immune dysregulation and allergy. Immunol Res 58:358-368. http://dx.doi.org/10.1007/s12026-014-8512-5
36. Cottrez F, Hurst SD, Coffman RL, Groux H. 2000. T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 165:4848-4853. http://dx.doi.org/10.4049/jimmunol.165.9.4848
37. Krogulska A, Polakowska E, Wasowska-Krolikowska K, Malachowska B, Mlynarski W, Borowiec M. 2015. Decreased FOXP3 mRNA expression in children with atopic asthma and IgE-mediated food allergy. Ann Allergy Asthma Immunol 115:415-421. http://dx.doi.org/10.1016/j.anai.2015.08.015
38. Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, Viola A, Odom S, Rivera J, Colombo MP, Pucillo CE. 2008. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 29:771-781. http://dx.doi.org/10.1016/j.immuni.2008.08.018
39. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY, Ziegler SF, Littman DR. 2008. TGFbeta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453:236-240. http://dx.doi.org/10.1038/nature06878
40. Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ. 2009. Identification of IL-17-producing FOXP3+ regulatory T cells in humans. Proc Natl Acad SciUSA106:4793-4798. http://dx.doi.org/10.1073/pnas.0900408106
41. Tanabe S. 2013. The effect of probiotics and gut microbiota on Th17 cells. Int Rev Immunol 32:511-525. http://dx.doi.org/10.3109/08830185.2013.839665
42. Melli LC, do Carmo-Rodrigues MS, Araújo-Filho HB, Sole D, de Morais MB. 15 May 2015. Intestinal microbiota and allergic diseases: a systematic review. Allergol Immunopathol (Madr) http://dx.doi.org/10.1016/j.aller.2015.01.013
43. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermudez-Humaran LG, Gratadoux JJ, Blugeon S, Bridonneau C, Furet JP, Corthier G, Grangette C, Vasquez N, Pochart P, Trugnan G, Thomas G, Blottiere HM, Dore J, Marteau P, Seksik P, Langella P. 2008. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 105:16731-16736. http://dx.doi.org/10.1073/pnas.0804812105
44. Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Licciardi PV, Robins-Browne RM, Tang ML. 2012. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol 23:674-681. http://dx.doi.org/10.1111/j.1399-3038.2012.01328.x
45. Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly Y, Glickman JN, Garrett WS. 2013. The microbial metabolites, shortchain fatty acids, regulate colonic Treg cell homeostasis. Science 341:569-573. http://dx.doi.org/10.1126/science.1241165
46. Stefka AT, Feehley T, Tripathi P, Qiu J, McCoy K, Mazmanian SK, Tjota MY, Seo GY, Cao S, Theriault BR, Antonopoulos DA, Zhou L, Chang EB, Fu YX, Nagler CR. 2014. Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci U S A 111:13145-13150. http://dx.doi.org/10.1073/pnas.1412008111
47. Kalach N, Kapel N, Waligora-Dupriet AJ, Castelain MC, Cousin MO, Sauvage C, Ba F, Nicolis I, Campeotto F, Butel MJ, Dupont C. 2013. Intestinal permeability and fecal eosinophil-derived neurotoxin are the best diagnosis tools for digestive non-IgE-mediated cow's milk allergy in toddlers. Clin Chem Lab Med 51:351-361
48. Nebot-Vivinus M, Harkat C, Bzioueche H, Cartier C, Plichon-Dainese R, Moussa L, Eutamene H, Pishvaie D, Holowacz S, Seyrig C, Piche T, Theodorou V. 2014. Multispecies probiotic protects gut barrier function in experimental models. World J Gastroenterol 20:6832-6843. http://dx.doi.org/10.3748/wjg.v20.i22.6832
49. Groschwitz KR, Hogan SP. 2009. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 124:3-20. http://dx.doi.org/10.1016/j.jaci.2009.05.038